Advanced Non-Squamous and Squamous NSCLC Market Size
Market Size in USD Bn
CAGR7.2%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 7.2% |
| Market Concentration | High |
| Major Players | AstraZeneca, Roche, Novartis, Pfizer, Bristol-Myers Squibb, Jiangsu Alphamab Biopharmaceuticals, Jiangsu HengRui Medicine and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Advanced Non-Squamous and Squamous NSCLC Market Analysis
The advanced non-squamous and squamous NSCLC market is estimated to be valued at USD 11.67.2 Bn in 2025 and is expected to reach USD 18.99 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032. This market has been witnessing steady growth over the past few years and this trend is expected to continue over the forecast period supported by increasing prevalence of lung cancer cases globally and growing demand for advanced and effective therapeutic options for treatment.